SCM
PBYI icon

Suffolk Capital Management’s Puma Biotechnology PBYI Stock Holding History

Suffolk Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,762
Closed -$2.07M – 146
2015
Q1 		$2.07M Buy
8,762
+528
+6% +$113K 0.24% 120
2014
Q4 		$1.56M Buy
8,234
+972
+13% +$216K 0.19% 124
2014
Q3 		$1.73M Buy
+7,262
New +$1.49M 0.22% 121
2013
Q3 		– Sell
-29,358
Closed -$1.3M – 150
2013
Q2 		$1.3M Buy
+29,358
New +$1.03M 0.19% 128

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Suffolk Capital Management's PBYI Position: Q2 2015 in Review

Suffolk Capital Management sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 8,762 shares — an estimated $2.07M sold.

Suffolk Capital Management first reported a position in PBYI in Q2 2013 and held it in 4 quarters. The position peaked at $2.07M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Suffolk Capital Management reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Suffolk Capital Management sold 8,762 Puma Biotechnology shares in Q2 2015, an estimated $2.07M.
  • Suffolk Capital Management first reported a position in Puma Biotechnology in Q2 2013 and held it in 4 quarters.
  • Suffolk Capital Management's Puma Biotechnology position peaked at $2.07M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Suffolk Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.